Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Voshol

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Proteomics. Clinical Applications|July 17, 2015
Proteomics in Pharmaceutical Research and DevelopmentPaul Cutler, Hans Voshol
Proteomics. Clinical Applications|March 13, 2015
Proteomics in pharmaceutical research and developmentPaul Cutler, Hans Voshol
The American Journal of Psychiatry|February 2, 2002
The human genome: proteomicsJan Van Oostrum, Hans Voshol
Current Molecular Medicine|August 29, 2003
Proteomics in the discovery of new therapeutic targets for psychiatric diseaseHans Voshol, Marc J Glucksman, Jan van Oostrum
Journal of Neurochemistry|December 11, 2002
Identification of a peptide mimic of the L2/HNK-1 carbohydrate epitopeMaryline Simon-Haldi, Ned Mantei, Jens Franke, et al.
The FEBS Journal|October 29, 2009
Antibody-based proteomics: analysis of signaling networks using reverse protein arraysHans Voshol, Markus Ehrat, Jens Traenkle, et al.
Sub-Cellular Biochemistry|October 24, 2007
LC-MALDI MS and MS/MS--an efficient tool in proteome analysisDieter R Mueller, Hans Voshol, Annick Waldt, et al.
Proteomics|February 13, 2002
Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradientsSjouke Hoving, Bertran Gerrits, Hans Voshol, et al.
Breast Cancer Research : BCR|April 7, 2016
Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibitionCedric Leroy, Pedro Ramos, Karen Cornille, et al.
Proteomics. Clinical Applications|December 8, 2010
Tracing pathway activities with kinase inhibitors and reverse phase protein arraysJan van Oostrum, Claudio Calonder, Daniel Rechsteiner, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Proteomics. Clinical Applications|July 17, 2015
Proteomics in Pharmaceutical Research and DevelopmentPaul Cutler, Hans Voshol
Proteomics. Clinical Applications|March 13, 2015
Proteomics in pharmaceutical research and developmentPaul Cutler, Hans Voshol
The American Journal of Psychiatry|February 2, 2002
The human genome: proteomicsJan Van Oostrum, Hans Voshol
Current Molecular Medicine|August 29, 2003
Proteomics in the discovery of new therapeutic targets for psychiatric diseaseHans Voshol, Marc J Glucksman, Jan van Oostrum
Journal of Neurochemistry|December 11, 2002
Identification of a peptide mimic of the L2/HNK-1 carbohydrate epitopeMaryline Simon-Haldi, Ned Mantei, Jens Franke, et al.
The FEBS Journal|October 29, 2009
Antibody-based proteomics: analysis of signaling networks using reverse protein arraysHans Voshol, Markus Ehrat, Jens Traenkle, et al.
Sub-Cellular Biochemistry|October 24, 2007
LC-MALDI MS and MS/MS--an efficient tool in proteome analysisDieter R Mueller, Hans Voshol, Annick Waldt, et al.
Proteomics|February 13, 2002
Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradientsSjouke Hoving, Bertran Gerrits, Hans Voshol, et al.
Breast Cancer Research : BCR|April 7, 2016
Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibitionCedric Leroy, Pedro Ramos, Karen Cornille, et al.
Proteomics. Clinical Applications|December 8, 2010
Tracing pathway activities with kinase inhibitors and reverse phase protein arraysJan van Oostrum, Claudio Calonder, Daniel Rechsteiner, et al.
Pageof 4